MANUFACTURING
JSE-listed pharmaceutical group Adcock Ingram Holdings expects to report a 24% to 25% year-on-year increase in earnings per share (EPS) to between 492c and 495c for the financial year ended June 30.
This compares with EPS of 396c posted in the prior financial year.
This content is only available to subscribers.
Forgot your password? Click here
Don't have any login details?
Free Trial Access